Literature DB >> 18209766

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

J Malcom1, O Arnold, Jonathan G Howlett, Anique Ducharme, Justin A Ezekowitz, Martin J Gardner, Nadia Giannetti, Haissam Haddad, George A Heckman, Debra Isaac, Philip Jong, Peter Liu, Elizabeth Mann, Robert S McKelvie, Gordon W Moe, Anna M Svendsen, Ross T Tsuyuki, Kelly O'Halloran, Heather J Ross, Errol J Sequeira, Michel White.   

Abstract

Heart failure is a clinical syndrome that normally requires health care to be provided by both specialists and nonspecialists. This is advantageous because patients benefit from complementary skill sets and experience, but can present challenges in the development of a common, shared treatment plan. The Canadian Cardiovascular Society published a comprehensive set of recommendations on the diagnosis and management of heart failure in January 2006, and on the prevention, management during intercurrent illness or acute decompensation, and use of biomarkers in January 2007. The present update builds on those core recommendations. Based on feedback obtained through a national program of heart failure workshops during 2006 and 2007, several topics were identified as priorities because of the challenges they pose to health care professionals. New evidence-based recommendations were developed using the structured approach for the review and assessment of evidence that was adopted and previously described by the Society. Specific recommendations and practical tips were written for best practices during the transition of care of heart failure patients, and the recognition, investigation and treatment of some specific cardiomyopathies. Specific clinical questions that are addressed include: What information should a referring physician provide for a specialist consultation? What instructions should a consultant provide to the referring physician? What processes should be in place to ensure that the expectations and needs of each physician are met? When a cardiomyopathy is suspected, how can it be recognized, how should it be investigated and diagnosed, how should it be treated, when should the patient be referred, and what special tests are available to assist in the diagnosis and treatment? The goals of the present update are to translate best evidence into practice, apply clinical wisdom where evidence for specific strategies is weaker, and aid physicians and other health care providers to optimally treat heart failure patients, resulting in a measurable impact on patient health and clinical outcomes in Canada.

Entities:  

Mesh:

Year:  2008        PMID: 18209766      PMCID: PMC2631246          DOI: 10.1016/s0828-282x(08)70545-2

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  193 in total

1.  Diastolic function impairment in alcoholics.

Authors:  J Fernández-Solà; J M Nicolás; J C Paré; E Sacanella; F Fatjó; M Cofán; R Estruch
Journal:  Alcohol Clin Exp Res       Date:  2000-12       Impact factor: 3.455

Review 2.  Primary care medicine in crisis: toward reconstruction and renewal.

Authors:  Gordon Moore; Jonathan Showstack
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

3.  Guidelines for the diagnosis and management of hypertrophic cardiomyopathy.

Authors:  Christopher Semsarian
Journal:  Heart Lung Circ       Date:  2006-12-26       Impact factor: 2.975

4.  Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study).

Authors:  N F Murphy; K MacIntyre; S Stewart; C L Hart; D Hole; J J V McMurray
Journal:  Eur Heart J       Date:  2005-09-23       Impact factor: 29.983

5.  Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.

Authors:  K MacIntyre; S Capewell; S Stewart; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; J J McMurray
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

6.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

7.  Discharge education improves clinical outcomes in patients with chronic heart failure.

Authors:  Todd M Koelling; Monica L Johnson; Robert J Cody; Keith D Aaronson
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

8.  Myocardial lesions induced by prolonged alcohol feeding in rhesus monkeys.

Authors:  S C Vasdev; R N Chakravarti; D Subrahmanyam; A C Jain; P L Wahi
Journal:  Cardiovasc Res       Date:  1975-01       Impact factor: 10.787

9.  Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure.

Authors:  S H Sardesai; A J Mourant; Y Sivathandon; R Farrow; D O Gibbons
Journal:  Br Heart J       Date:  1990-04

10.  Dying trajectories in heart failure.

Authors:  Merryn Gott; Sarah Barnes; Chris Parker; Sheila Payne; David Seamark; Salah Gariballa; Neil Small
Journal:  Palliat Med       Date:  2007-03       Impact factor: 4.762

View more
  25 in total

1.  Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines.

Authors:  Lizebeth Cox; Marita Kloseck; Richard Crilly; Carol McWilliam; Laura Diachun
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

2.  Understanding palliative care on the heart failure care team: an innovative research methodology.

Authors:  Lorelei A Lingard; Allan McDougall; Valerie Schulz; Joshua Shadd; Denise Marshall; Patricia H Strachan; Glendon R Tait; J Malcolm Arnold; Gil Kimel
Journal:  J Pain Symptom Manage       Date:  2012-09-25       Impact factor: 3.612

3.  Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter.

Authors:  Stephen Pizzale; Robert Lemery; Martin S Green; Michael H Gollob; Anthony S L Tang; David H Birnie
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

4.  Referral and use of heart failure clinics: what factors are related to use?

Authors:  Shannon Gravely; Liane Ginsburg; Donna E Stewart; Susanna Mak; Sherry L Grace
Journal:  Can J Cardiol       Date:  2012-02-25       Impact factor: 5.223

5.  Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study.

Authors:  Javed Butler; Lampros Papadimitriou; Vasiliki Georgiopoulou; Hal Skopicki; Sandra Dunbar; Andreas Kalogeropoulos
Journal:  Circ Heart Fail       Date:  2015-05       Impact factor: 8.790

Review 6.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

Review 7.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

8.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Authors:  Jonathan G Howlett; Robert S McKelvie; J Malcolm O Arnold; Jeannine Costigan; Paul Dorian; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Philip Jong; Simon Kouz; Peter Liu; Elizabeth Mann; Gordon W Moe; Ross T Tsuyuki; Heather J Ross; Michel White
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

9.  Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.

Authors:  Ruth Isserlin; Daniele Merico; Rasoul Alikhani-Koupaei; Anthony Gramolini; Gary D Bader; Andrew Emili
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

10.  Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.

Authors:  R Jung; M W Wendeler; M Danevad; H Himmelbauer; R Gessner
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.